GlassScriptPhysician profile
Derek Gindi
NPI 1376034447
$2,286.03
in general payments reported to CMS, 2019-2025
9 companies · $70.95 in 2025
The $70.95 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.69 · 2022: $155 · 2023: $950 · 2024: $1,085 · 2025: $70.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,106.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $927.88 | 2023-2025 | |
| Boston Scientific Corporation | $623.66 | 2022-2024 | Resolution 360 Ultra Clip, Resolution Clip, Orcapod |
| Mallinckrodt Hospital Products INC. | $265.92 | 2023 | Terlivaz |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Zeposia |
| Ipsen Biopharmaceuticals, INC | $124.96 | 2024 | Iqirvo |
| Regeneron Healthcare Solutions, INC. | $96.47 | 2023 | Dupixent |
| Ardelyx, INC. | $75.24 | 2023-2024 | Ibsrela |
| Lilly USA, LLC | $24.69 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.21 | 2023 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Gindi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.